NCT01954368View on ClinicalTrials.gov

Intranasal Sufentanil Pain-management at Entrance of Emergency Department : Influence on Pain-relief Delay

PHASE4CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Single Traumatic Limb Injury With Severe Pain (Score > 5/10 on Numerical Pain Scale)
Interventions
DRUG

Placebo

"As soon as possible from ED admission, using a study drug volume schedule, triage nurse will administer to the patient a planned weight-based volume of intranasal placebo (normal saline solution).~Half of the dose will be administrated in each nostril. The patient will then rapidly be brought to emergency room and after his pain being reassessed, appropriate treatment (following current recommendations) will be given by the ED nurse."

DRUG

Sufentanil

"As soon as possible from ED admission, using a study drug volume schedule, triage nurse will administer to the patient a weight-based volume (corresponding to 0,4 mcg/kg) of intranasal sufentanil.~Half of the dose will be administrated in each nostril. The patient will then rapidly be brought to emergency room and after his pain being reassessed, appropriate treatment (following current recommendations) will be given by the ED nurse."

Trial Locations (1)

06000

Emergency Department, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT01954368 - Intranasal Sufentanil Pain-management at Entrance of Emergency Department : Influence on Pain-relief Delay | Biotech Hunter | Biotech Hunter